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Abstract: Hepatitis C Virus (HCV) assembly process is the least understood step in the 
virus life cycle. The functional data revealed by forward and reverse genetics indicated that 
both structural and non-structural proteins are involved in the assembly process. Using 
confocal and electron microscopy different groups determined the subcellular localization 
of different viral proteins and they identified the lipid droplets (LDs) as the potential viral 
assembly site. Here, we aim to review the mechanisms that govern the viral proteins 
recruitment to LDs and discuss the current model of HCV assembly process. Based on 
previous examples, this review will also discuss advanced imaging techniques as potential 
means to extend our present knowledge of HCV assembly process. 
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1. Introduction 
Hepatitis C virus (HCV) represents a global health problem with 130 million people infected 
worldwide [1]. HCV infection is generally chronic and the virus primarily infects human hepatocytes, 
which over time leads to chronic inflammation of the liver, progressive fibrosis and development of 
hepatocellular carcinoma.  
HCV is a positive stranded RNA virus, which belongs to the Flaviviridae family [2]. Upon entry in 
the hepatocyte, the viral genome is translated into a polyprotein, which is sequentially cleaved by both 
endogenous and viral peptidases to produce 10 mature proteins (Figure 1). The N-terminus of the 
polyprotein consists of the structural proteins: the core protein and the envelope glycoproteins, E1 and 
E2. The C-terminal part comprises the non-structural proteins NS3 to NS5B, which are the viral 
components of the replication complex. Between the structural and non-structural proteins there are 
two additional proteins most likely non-structural, called p7 and NS2. They are dispensable for 
replication, but they are emerging as major players in HCV assembly. 
Figure 1. Representation of the genetic organization of hepatitis C virus (HCV). The   
N-terminal part of the genome comprises the structural elements core (C)—the forming 
unit of the capsid and the envelope glycoproteins, E1 and E2. The C-terminal part of the 
genome consists of the non-structural proteins (NS3 to NS5B) responsible for HCV 
genome amplification. p7 and NS2 are non-structural protein dispensable for replication, 
but essential for viral assembly. HCV proteins are synthesized as a polyprotein, which is 
processed by endogenous proteases (full circle—signal peptide peptidase, open diamond—
signal peptidase) or viral encoded proteases: NS2 (full diamond) and NS3 (open circle) to 
generate 10 mature proteins. 
 
 
For reasons that remain partly unknown, serum-derived HCV cannot be propagated in cell culture. 
Therefore HCV research has largely depended on surrogate systems. For instance, replicon systems 
were developed to investigate HCV genome replication [3], and replication-deficient retroviruses 
pseudotyped with HCV envelope glycoproteins (HCVpp) were engineered to study HCV entry [4–6]. 
Unfortunately, no convincing surrogate model could be developed to study HCV assembly, and for this 
reason, HCV morphogenesis is the least understood step in the life cycle of this virus. Nevertheless, 
in 2005, several teams finally succeeded in propagating HCV in cell culture (HCVcc) [7–9]. Since then, 
data have been accumulating regarding the assembly events. The peculiarity of HCV and the other 
members of the Flaviviridae family in general is the crucial role played by both structural and 
non-structural proteins in the assembly process. Indeed, genetic, cell biology and biochemistry data 
highlight the role of practically all HCV proteins in the assembly process (reviewed in [10]). Another 
major specific feature of HCV is its strong dependence on lipoprotein biogenesis for its morphogenesis Viruses 2011, 3  
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(reviewer in [11]). Despite the progress made on HCV assembly during the last six years, there is still 
no unified picture of the assembly process. In order to reach this goal, different groups have been using 
electron and fluorescence microscopy trying to visualize the viral particle and to get insight into the 
scenario of the assembly process, respectively. This review aims to summarize the achieved progress 
and to suggest a working model and different perspectives. 
2. HCV Protein Components 
The core protein and the envelope glycoproteins are the known viral protein components of HCV 
particle (Figure 1). Core is a dimeric protein [12] with two domains: a charged hydrophilic domain 
(D1) supposed to interact with the viral RNA during nucleocapsid formation and a hydrophobic 
domain (D2) which binds endoplasmic reticulum (ER) outer leaflet [13]. The envelope glycoproteins, 
E1 and E2, are the protein components of the viral envelope (reviewed in [14]). They are type I 
transmembrane glycoproteins with up to five and eleven glycans, respectively. E1 and E2 form a 
non-covalent heterodimer, which is believed to be the basic functional unit of the viral envelope [15]. 
These proteins play a major role during virus entry into the hepatocyte and their entry functions are 
tightly dependent on proper assembly of the viral particle. Recently, E1E2 heterodimers were shown to 
form large complexes stabilized by intermolecular disulfide bridges on the surface of the viral particle 
[16]. These covalent interactions likely play a role in the spatiotemporal control of the entry process. 
The p7 and NS2 polypeptides are non-structural proteins dispensable for genomic replication. p7 is 
a small viroporin with ion channel properties (reviewed in [17]). It is involved in the assembly and 
release of the viral particle both in cell culture and in in vivo models [18–20]. NS2 is a multispanning 
transmembrane protein with multiple functions. It has autoprotease activity catalyzing the processing 
of its C-terminus. Recently, it was also reported to be central for the assembly process by connecting 
the structural and non-structural proteins during virus assembly (reviewed in [10]). 
The non-structural proteins NS3 to NS5B are the viral components of the replication complex 
(Figure 1). The NS3 protein possesses two domains: a serine protease and a helicase. NS3 protease 
domain forms a complex with NS4A, a small hydrophobic polypeptide, which serves as a cofactor. 
This protease domain processes the downstream cleavage sites of the polyprotein. This processing is 
essential for viral replication, and as a consequence it is the most advanced drug target for anti-HCV 
therapy [21]. Beside its crucial role in replication, NS3 was also shown to be involved in the assembly 
process [22]. NS4B is a hydrophobic protein, which has four transmembrane passages and it induces 
specific changes in the membranous architecture, called “membranous web” [23]. The membranous 
web is essential for the efficacy of the viral replication [24]. NS4B seems also to participate in the 
assembly process [25]. NS5A is a multifunctional protein, which is involved in both replication and 
virion assembly [26–28]. Besides its N-terminal amphipathic region that enables the protein to bind to 
phospholipid monolayers, NS5A has three domains with different roles. Domain I is well structured 
and is involved in replication [29], whereas domains II and III are natively unfolded with domain III 
playing a role in virion assembly [26,28,30–32]. NS5A has two phosphorylation states (basal and 
hyperphophorylated), which affect the assembly process and regulate viral RNA replication [28,33]. 
NS5B, being an RNA-dependent RNA polymerase, is the central component of the replication 
complex. NS5B is associated to ER membrane by a C-terminal transmembrane domain (reviewed Viruses 2011, 3  
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in [34]). NS5B replicates the viral genome with the help of host specific factors and the other viral 
proteins of the replication complex. 
As mentioned above, both structural and non-structural proteins take part in the assembly process. 
Thus, the particle formation should be a tightly synchronized event in order to switch from replication 
to assembly. Ideally, to completely understand the process, we should visualize it. Hence, we will 
present the progress made in the imaging of each viral/endogenous element involved in HCV 
morphogenesis and how they crosstalk topologically and functionally towards the assembly event. We 
will then discuss the relevance of the models and techniques used to the understanding of HCV particle 
formation. Finally, we will suggest some hypotheses and new approaches to validate them. 
3. Core and Lipid Droplets in HCV Assembly 
As expected, core protein is central to the assembly event as the constitutive unit of the 
nucleocapsid [35]. It is an α-helical protein which oligomerizes in vitro through its basic charged D1 
domain (reviewed in [2]). D2 domain provides core lipid binding properties anchoring the protein in 
the outer leaflet of the ER [13]. By confocal fluorescence microscopy, it was shown that besides its ER 
localization, core decorates the surface of lipid droplets (LDs) [36,37]. LD is a dynamic organelle, 
which stores lipids as triacylgricerides (TAGs) and cholesteryl esters surrounded by a phospholipid 
monolayer. LD surface holds a complex proteome with different functions [38]. LDs are assumed to 
arise from TAGs accumulation between the two ER leaflets followed by detachment into the cytosol 
(cytLD) or ER lumen (luLD) [39] (Figure 2). As D2 domain enables core to float in the outer leaflet of 
the ER, the determinants of core-LD association reside in the same domain [40]. Thus, nuclear 
magnetic resonance studies showed that D2 consists of two amphiphatic helices separated by a 
hydrophobic loop. Confocal microscopy analyses with fluorescent reporters identified crucial residues 
for core-LD association in both structural components of D2 [13]. A second determinant of core-LD 
association is the processing of the core C-terminus by a signal peptide peptidase [40]. Importantly, the 
subcellular localization of core around the LDs was confirmed in the HCVcc system [41–43]. By 3D 
reconstruction of confocal images taken during infection, it was shown that core is gradually 
decorating the surface of the LDs [41]. The extent of LD core coverage correlated with the production 
of infectious particles.  
In addition to being located around LDs, core protein also induces their redistribution from a 
scattered distribution within the cytoplasm to a perinuclear region [44]. Viral RNA is replicated in 
special perinuclear membranes called membranous webs [24], and the LD redistribution might create 
the lipid microenvironment where the structural and non-structural elements involved in assembly are 
most likely to interact [42]. Adipose differentiation-related protein (ADRP) is a major protein associated 
with LDs in the hepatocyte [45]. Interestingly, core protein dislocates ADRP from the surface of LDs, 
determining its microtubule dependent movement towards the microtubule organizing centre [44]. This 
model assumes that LD redistribution enhances the encounter between the core and the replication 
complexes during the assembly event [44]. However, core redistribution around the nucleus could also 
be explained by the LD regression/regeneration model. It suggests that cytoplasmic LDs regress at ER 
membranes and regenerate at distant domains rich in core protein, which replaces the ADRP on the Viruses 2011, 3  
 
 
2242
surface of LDs, generating their formation and aggregation around the nucleus [45]. In both cases, the 
core-LD association is directly proportional to the extent of LD redistribution in the perinuclear region. 
Figure 2. Working model of HCV assembly. Viral assembly is triggered by the encounter 
of three modules: core, E1E2p7NS2 complex and the replication complex (RC). The 
assembly site is supposed to be in the membranous microenvironment of the lipid droplet 
(LD) and the endoplasmic reticulum (ER). The driving force of viral budding potentially 
comes from three directions: pushing force of the nascent nucleocaspsid, the pulling force 
of envelope proteins which might stabilize the viral surface architecture by intermolecular 
disulfide bridges and the force of the nascent luminal LD (luLD) between the ER leaflets. 
The result is a hybrid lipoviroparticle, which acquires ApoE presumably by its lipid 
component and in primary hepatocytes the lipoprotein moiety may mature into a 
VLDL-like structure (adapted from [46]). MTP stands for microsomal triglyceride transfer 
protein that is involved in the VLDL pathway. sER/mw is for smooth ER/ membranous 
web where the HCV replication is believed to take place.  
 
 
Interestingly, when comparing viruses with different assembly efficacies, it was found that the 
core-LD extent of association is inversely proportional to virion production [47]. Moreover, the main 
determinant of the different assembly efficacies was identified in the D2 of core protein. Indeed, a Viruses 2011, 3  
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single mutation in this domain was shown to increase virion production, whereas it reduced its 
distribution around the LDs [47]. If one considers the microtubule redistribution model, the more 
efficiently the core protein on the incoming LDs is used in the assembly process, the faster the LD 
returns to its cytosolic localization probably by ADRP recoating. We should expect that the more 
mobile the core protein, the better it will partition between LDs and the assembly site. However, 
fluorescence recovery after photobleaching (FRAP) analyses indicate that D2 domain mobility is 
inversely proportional to virion production [47]. The authors suggest that higher rigidity of the core 
protein can increase the chances for the protein to interact with the other viral elements during the 
assembly process (e.g., viral RNA, NS5A). Another titer-enhancing mutation in core protein of the 
JFH1 isolate is the double substitution F172C, P173S near the C-terminus of the mature protein [48]. 
The palmitoylation of C172 could be the determinant for this more efficient assembly [49]. 
Interestingly, this post-translational modification also correlates with an increased partitioning of core 
to smooth ER membranes associated with LDs, and lower coverage of the LD surface. 
On the other hand, when the core-LD association is totally prevented, virus assembly is drastically 
impaired. Indeed, infectivity, viral RNA and core release are seriously inhibited in these conditions 
[41,42]. Importantly, there is a close association between recruitment of other viral proteins to LDs and 
the core-LD association. Indeed, NS2, NS3, NS4AB, NS5A, NS5B localize around the LDs in infected 
cells [42,44,50–52]. Electron microscopy images showed that while core is tightly associated to LD, 
NS2, NS5A, E2 and probably E1 and other non-structural proteins also colocalize at close proximity of 
the LDs [42,52]. Furthermore, in situ hybridization analyses indicate that plus and minus strand viral 
RNAs are also found at the proximity of LDs [42]. In contrast, viruses containing defective mutations 
in core-LD association do not show accumulation of the other viral elements around the LDs [42,52]. 
The partition of core between LD and ER membranes and the consequent presence of other viral 
proteins around the LDs is therefore central to the assembly process.  
It is important to note that other proteins can influence the localization of core. Indeed, it was 
shown recently that p7 and NS2 induce the redistribution of core from LD to ER membrane, 
paralleling the increase of the viral titers and subsequently assembly efficacy [53]. The channel activity 
of p7 does not seem to influence this core redistribution. Rather, elements possibly involved in p7-NS2 
protein-protein interactions play a role in core subcellular localization [53]. p7 and NS2 have indeed 
been shown to interact [52], and there is a functional connection between p7 and NS2 in the assembly 
process as discussed in the next section. Besides the viral proteins involved in assembly, the core-LD 
association can also be influenced by endogenous proteins. Diacylglycerol acyltransferase-1 (DGAT1), 
an enzyme involved in LD morphogenesis has recently been demonstrated to interact with core and to 
enable core-LD association and virus production [54].  
4. p7 and NS2 Are Central Players in HCV Morphogenesis 
The participation of non-structural proteins in virion assembly appears to be the paradigm for the 
Flaviviridae family (reviewed in [55]). p7 and NS2 are dispensable for viral replication, but they are 
crucial for virion assembly and release [18,20,56]. An appropriate subcellular localization of these 
proteins is therefore essential for HCV morphogenesis. In HCV-infected cells, NS2 accumulates in 
dotted structures, which are derived from the ER membranes and are juxtaposed to LDs [50,52] Viruses 2011, 3  
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(Figure 3). By electron microscopy, NS2 was shown to form clusters in the proximity of LDs in a 200 
nm range, which is the resolution of the confocal microscopy [52]. These NS2-containing structures 
have been proposed to be the subcellular sites of HCV assembly. Indeed, NS2 positive dots co-localize 
with E1 and E2 envelope glycoproteins as well as with NS3 and NS5A non-structural proteins. 
Furthermore, these dots are juxtaposed to core protein, which decorates the LDs (Figure 3). The 
co-localization of all these proteins indicates that membranes harboring replication complexes are 
juxtaposed to the LDs, however they are in a more peripheral position of the LDs as compared to core 
protein [42]. When core-LD association is prevented, the NS2 dotted structures still form and their 
number increases significantly [52]. Thus, it seems that the accumulation of the envelope and 
non-structural proteins at the assembly sites takes place prior to the arrival of core-loaded LDs. The 
presence of core might trigger the assembly event since in its absence there is an increase in structures 
enriched in NS2 and envelope proteins. It is worth noting that core interacts directly with NS5A and 
this might trigger the assembly process [31].  
Figure 3. NS2 protein accumulates at the site of virus assembly. Confocal image of an 
electroporated hepatocyte with the HCV genome shows the accumulation of NS2 (red) and 
core protein (blue) in close proximity to cytoplasmic LDs (green), the putative site of HCV 
assembly. The nucleus was counterstained with DAPI (grey).  
 
 
Genetic data suggest that the transmembrane domain of NS2 is a site of interactions with structural 
and non-structural proteins (reviewed in [10]). In addition, biochemical experiments indicate that NS2 
interacts with E1, E2, p7 and NS3 [50,52,57] to form a large hetero-oligomeric complex, 
E1E2p7NS2NS3 [57]. Hence, it is likely that some of these proteins travel together to the assembly 
site. It seems to be the case for E2, p7 and NS2 since deletion of p7 or of the transmembrane 
domain  of  E2 impairs their interaction with NS2 as well as the formation of assembly sites [52]. 
Mutagenesis experiments indicate that the transmembrane region of NS2 is a major determinant of its 
subcellular localization [52]. Together, these data reinforce the model where E1E2 heterodimer, NS2 
and p7 form a functional unit, which migrates to NS5A positive membranes, possibly populated by 
replication complexes. Viruses 2011, 3  
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When NS2 complexes arrive or form at the NS5A positive membranes, a signal should be sent to 
initiate the assembly process. As discussed in detail in the next section, NS5A phosphorylation at 
specific sites in domain III is essential for HCV assembly and core-NS5A direct interaction [28,31]. 
Interestingly, mutation of these phosphorylation sites in NS5A impaired the formation or stabilization 
of NS2 dotted structures suggesting a functional connection between NS2 and NS5A in the assembly 
event [52]. Thus, NS5A phosphorylation might initiate the core-NS5A interaction triggering the 
assembly process, which is characterized by NS2 dotted structures bridging the structural and 
non-structural protein towards virion formation.  
Unfortunately, the data about p7 subcellular localization are missing from HCVcc system due to the 
lack of reagents. While it was shown that in recombinant systems p7 localizes both in ER and in 
mitochondria, in the context of the full length HCV replicon the protein had an exclusive ER 
localization [58,59]. Until p7 is visualized in a functional infectious virus, we can only speculate that 
p7 would follow at least partially NS2 localization since these two proteins interact and p7 is a crucial 
determinant of NS2 subcellular localization [50,52,57]. 
5. HCV Envelope Glycoproteins and Viral Morphogenesis 
HCV envelope glycoproteins, E1 and E2, are major components of the viral particle. These proteins 
consist of a large N-terminal ectodomain and a C-terminal transmembrane domain, anchoring each 
glycoprotein in a lipid bilayer. The transmembrane domains contain ER retention signals [60,61], 
responsible for their subcellular localization [43]. In infected cells, E1 and E2 form a non-covalent 
heterodimer, which is believed to be the basic functional unit of the viral envelope, whereas 
virion-associated envelope glycoproteins form large covalent complexes stabilized by disulfide bridges 
[16]. The presence of disulfide bridges between HCV envelope glycoproteins suggests that lateral 
protein-protein interactions assisted by disulfide-bond formation might play an active role in the 
budding process of HCV particle. Although they are retained in the ER, over time, HCV envelope 
glycoproteins co-localize with NS2 dotted structures. This indicates that NS2 sub-compartment is a 
potential virion assembly platform enriched in envelope proteins and non-structural element involved 
in both replication and assembly (e.g., NS3 and NS5A) [52]. 
6. Non-Structural Proteins of the Replication Complex Are Involved in HCV Assembly 
As for other members of the Flaviviridae family [55], HCV non-structural proteins of the 
replication complex are also involved in virus assembly (reviewed in [10]). Viral replication takes 
place at specific membranous domains called membranous webs [24]. In the context of the 
subgenomic replicon, it was shown that the replication complex belongs to two populations: large, 
static structures representing the membranous webs and small replication complexes which travel long 
distances in a microtubule dependent manner [62].  
In agreement with the functional data, NS3, NS4A, NS4B, NS5A and NS5B were found to 
accumulate in the proximity of the LDs, at the proposed site of viral assembly [42,43]. Core-LD 
association is crucial for the recruitment of the non-structural elements possibly present in active 
replication complexes around the LDs [42]. However, it is not clear how the non-structural proteins are 
recruited in the proximity of the LDs. It has been supposed that core-induced LD redistribution Viruses 2011, 3  
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increases the encounter rate between LDs, core and replication complexes [44]. Another possibility is 
that LDs form in core rich membrane domains proximal to replication complexes [45,63]. In any case 
there should be a mechanism, which controls the distribution of non-structural proteins between the ER 
and LDs. NS5A seems to be a crucial factor in the localization of all the replication complex elements, 
possibly determining the recruitment of active replication complexes at the assembly sites [42]. In 
line with this scenario, double stranded RNA was found associated with NS5A in the proximity of 
LDs [64]. NS5A is also believed to be an important connecting element between the replication and 
assembly steps [26,28,33]. An interesting structural element of NS5A is its amphipathic N-terminus 
which enables the protein to bind to phospholipid monolayers. It is crucial for the protein localization 
and function during replication [65,66]. The same element might be also involved in positioning NS5A 
during the assembly process. 
NS5A plays a central role in the recruitment of the replication complexes around the LDs. Indeed, a 
triple alanine substitution in domain I of NS5A prevents the recruitment of the protein and other 
non-structural proteins to the LDs [42]. On the other hand, domain I is involved in the mode of action 
of a class of antiviral compounds. These compounds redistribute the NS5A from punctuated 
membranous webs to LDs, drastically inhibiting the replication process. Interestingly, the effect is 
specific to NS5A but not the other non-structural proteins in the replication complex [67]. Thus, 
domain I may be involved in both preserving the NS5A function in the active replication complexes 
and mobilizing these complexes towards LDs for assembly to take place.  
We have a poor understanding of what happens when the replication complexes encounter the 
structural elements in the proximity of LDs to trigger the particle assembly. Deletion analyses in 
domain III of NS5A showed that this domain is crucial for virus assembly [26,28,31]. Deletions in 
domain III do not affect the subcellular localization of NS5A around the LDs. They rather impair core 
co-localization with LDs [26,28]. Thus, domain III is involved in a later stage of assembly when the 
replication complex is already present in the proximity of LDs. It has been suggested that domain III of 
NS5A might be involved in the recruitment of replication complexes to core vicinity [26]. A direct 
interaction between core and NS5A has been reported [31]. Furthermore, three phosphorylated serine 
residues in the C-terminus of domain III are crucial for this interaction as well as for virus production 
[28,31]. 
Beside the replication complex proteins, NS5A also influences the subcellular localization of other 
viral proteins involved in viral assembly like NS2. The dotted structures enriched in envelope proteins 
juxtaposed to core and LDs are stabilized by the phosphorylation of one serine residue in domain III of 
NS5A, which is essential for viral assembly [28,52]. 
7. HCVcc Model and Assembly Imaging 
Although HCV can now be propagated in cell culture, the amount of viral particles produced 
remains rather modest as compared to other viruses. In the current experimental conditions, we can 
roughly estimate that Huh7 cells produce in the range of one infectious HCV particle per cell per 
infectious cycle. Imaging such a rare event remains therefore very challenging. 
At this stage of our knowledge, we can propose that viral assembly occurs in three steps: 
nucleocapsid formation, budding and maturation to the infectious particle [68]. VLDL pathway is Viruses 2011, 3  
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closely related to the infectious particle production. Some reports suggested that both ApoB and MTP 
are involved in HCV assembly [68,69]. The virion was shown to have a VLDL and LDL like lipid 
composition and to be associated to ApoE which is essential for the infectious virus assembly [68–71]. 
It is not clear in which step of viral assembly ApoE is involved. Core secretion is not significantly 
affected by ApoE [72,73]. Hence, ApoE might be involved either in the budding process or in particle 
maturation in the ER and a post-ER compartment. The latter step could be more likely to be controlled 
by ApoE since infectious particle release is dependent on ApoE secretion [72]. It is believed that the 
lipoviroparticle may fuse further with VLDL in the ER and follow a VLDL like maturation in the 
secretory pathway. Due to an inefficient VLDL assembly pathway in Huh7 cells, this step is impaired 
(Figure 2) (reviewed by [46]). Thus, we may conclude that the HCVcc system is suitable for imaging 
of the first two stages of the assembly process. For a better understanding of the assembly, systems 
with higher specific infectivity would be required. In principle that could be obtained in primary 
hepatocytes based systems which are beginning to emerge [74,75].  
8. Imaging Techniques and HCV Assembly 
The majority of the studies of HCV assembly have been performed by confocal microscopy on 
fixed cells. To answer questions related to the dynamic of the assembly process, viral proteins should 
be functionally labeled with fluorescent tags in the context of an infectious virus and more advanced 
techniques like spinning disk and time-lapse confocal microscopy should be used. These would bring 
valuable insight in the understanding of the connection between LDs and all the viral proteins involved 
in HCV assembly.  
It would be also of great interest to use higher resolution approaches such as stimulated emission 
depletion (STED) microscopy, stochastic optical reconstruction microscopy (STORM) or photoactivated 
localization microscopy (PALM), which have enhanced resolution that is up to 10 times higher or 
better than that of conventional optical microscopy, with lateral resolution to approximately 20 nm and 
axial resolution to approximately 50 nm, comparing to the classical light microscopy resolution limits 
of 200 nm and 600 nm, respectively [76]. The use of these techniques could help visualize the 
encounter of the different modules (Core, E1E2p7NS2, and the replication complex), which cooperate 
during HCV assembly. 
Electron microscopy is still a method of choice for high resolution imaging of the localization of 
intracellular biomolecules, which often is crucial to understand their function. Traditionally, light and 
electron microscopy observations are carried out in different samples. This makes it difficult to 
observe rare events, or events occurring in a limited number of cells in a population, a situation 
thought to occur in the study of HCV assembly, as discussed earlier. Another limitation in electron 
microscopy analyses of HCV assembly is the heterogeneity of HCV particles, which makes them 
difficult to visualize in infected cells [77]. The development of various correlative fluorescence and 
electron microscopy techniques now allows for high resolution imaging by electron microscopy of the 
same structure observed by light microscopy. Thus, an event visualized at low resolution by light 
microscopy or a single cell displaying a phenotype of interest within a population can now also be 
studied at high resolution by electron microscopy [78]. The use of correlative fluorescence and 
electron microscopy should help improve our knowledge of the morphology of HCV assembly sites. Viruses 2011, 3  
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Assembly can also be viewed as a series of regulated protein-protein interactions. Deciphering these 
interactions within the cell will require fluorescence-based techniques capable of measuring these 
interactions  in vivo, such as fluorescence resonance energy transfer (FRET) or Fluorescence 
cross-correlation spectroscopy (FCCS) techniques. FRET has already been used successfully to image 
HIV virion morphogenesis [79]. Such kinds of assays should provide us with the opportunity of 
revealing the chronology, dynamics and intracellular distribution of interactions occurring during HCV 
assembly. However, a major drawback in applying these techniques to HCV assembly has been the 
great difficulties in inserting fluorescent tags in HCV proteins in the context of an infectious virus. A 
major step towards this goal has been achieved with the construction of a functional recombinant virus 
harboring a fluorescently labeled NS5A by adaptation of a full-length EGFP-NS5A replicon [80,81].  
9. Conclusions 
Imaging of HCV infected cells together with biochemical studies are beginning to provide some 
hints on HCV morphogenesis. Our current working model is depicted in Figure 2. There are three 
functional modules involved in assembly: core, NS2 complexes containing the envelope proteins, p7 
and maybe NS3, and the replication complexes. NS2 complexes reach the replication complexes 
independently of core protein. Core protein induces LD relocalization/regeneration, enabling the three 
modules of assembly to encounter in a favorable assembly environment. Viral budding is induced by 
the pushing force of the nucleocapsid [35] corroborated with the pulling force of envelope 
proteins [82] and potentially the accumulating neutral lipids between the two leaflets of the ER. The 
result would be a hybrid lipoviroparticle [83], which matures further by interaction with ApoE. In cells 
with an efficient VLDL pathway metabolism, the lipoprotein moiety may mature into a VLDL-like 
structure [46].  
Although a picture is now emerging on the assembly process, there are still many unanswered 
questions. One of the most basic questions concerning HCV assembly is where does it exactly occur? 
The answer will probably come when we will be able to image the assembly intermediates using high 
resolution imaging techniques. A second question is how the assembly components are meeting at the 
assembly sites? This problem concerns the different scenarios of core-LD association and LD 
intracellular trafficking, the topological and functional connection between the replication complexes, 
LD and core protein and how they participate alongside the envelope proteins towards the budding 
process? What is the role of p7 and NS2 in the assembly process? A third question relates to the 
involvement of lipid metabolism in particle formation/maturation. VLDL pathway is closely related to 
infectious particle production [68–70]. ApoE was shown to be essential for infectious virus assembly 
(reviewed in [46]). Is ApoE crucial for nucleocapsid assembly, budding or maturation? Core secretion 
is not significantly affected by ApoE [72,73]. Hence ApoE might be involved either in the budding 
process or in particle maturation in the ER and a post-ER compartment. The latter step could be more 
likely to be controlled by ApoE since viral release is dependent on ApoE secretion [72]. Imaging the 
relationship between HCV particle and VLDL pathway would be quite difficult due to the major 
endogenous background of VLDL pathway components. At the end, new cell culture models, advances 
in viral protein labeling and higher resolution microscopy techniques will contribute to a better 
understanding of the HCV assembly process, paving the way for new antiviral strategies. Viruses 2011, 3  
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